Infection-prevention on Ti implants by controlled drug release from folic acid/ZnO quantum dots sealed titania nanotubes
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 85, 214-224
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (51422102, 51671081)
- National Key Research and Development Program of China (2016YFC1100600, 2016YFC1100604)
This publication has 56 references indexed in Scilit:
- Acid degradable ZnO quantum dots as a platform for targeted delivery of an anticancer drugJournal of Materials Chemistry, 2011
- Plasma-Modified Biomaterials for Self-Antimicrobial ApplicationsACS Applied Materials & Interfaces, 2011
- pH-Triggered Controlled Drug Release from Mesoporous Silica Nanoparticles via Intracelluar Dissolution of ZnO NanolidsJournal of the American Chemical Society, 2011
- New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery responseActa Biomaterialia, 2010
- Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of DocetaxelBiomaterials, 2010
- Ti based biomaterials, the ultimate choice for orthopaedic implants – A reviewProgress in Materials Science, 2009
- Reducing implant-related infections: active release strategiesChemical Society Reviews, 2006
- Drug/device combinations for local drug therapies and infection prophylaxisBiomaterials, 2006
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Antibacterial Effect of Zinc Oxide in VitroScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1990